載入...
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Alzheimer’s disease is a neurological disorder that results in cognitive and behavioral impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs, often fail due to their poor solubility, lower bioavailability, and ineffective ability to cross the blood–brain barrie...
Na minha lista:
| 發表在: | Int J Nanomedicine |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4531021/ https://ncbi.nlm.nih.gov/pubmed/26345528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S87148 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|